Analyte monitoring device and methods of use
DC CAFCFirst Claim
1. A sensor assembly to monitor an analyte, the sensor assembly comprising:
- a transcutaneous electrochemical sensor comprising non-leachable, analyte-responsive enzyme; and
a sensor control unit adapted for placement on skin and adapted for receiving a portion of the transcutaneous electrochemical sensor, the sensor control unit comprising a rf transmitter that is configured and arranged to intermittently and repeatedly transmit data related to analyte-dependent signals generated by the electrochemical sensor.
5 Assignments
Litigations
0 Petitions
Reexaminations
Accused Products
Abstract
An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.
-
Citations
56 Claims
-
1. A sensor assembly to monitor an analyte, the sensor assembly comprising:
-
a transcutaneous electrochemical sensor comprising non-leachable, analyte-responsive enzyme; and
a sensor control unit adapted for placement on skin and adapted for receiving a portion of the transcutaneous electrochemical sensor, the sensor control unit comprising a rf transmitter that is configured and arranged to intermittently and repeatedly transmit data related to analyte-dependent signals generated by the electrochemical sensor. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
-
11. An analyte monitoring system to monitor a level of an analyte, the analyte monitoring system, comprising:
-
a transcutaneous electrochemical sensor comprising non-leachable, analyte-responsive enzyme;
a sensor control unit adapted for placement on skin and adapted for receiving a portion of the transcutaneous electrochemical sensor, the sensor control unit comprising a rf transmitter that is configured and arranged to intermittently and repeatedly transmit data related to analyte-dependent signals generated by the electrochemical sensor; and
a display unit comprising a rf receiver to receive the data from the sensor control unit and a display coupled to the rf receiver for displaying an indication of a level of the analyte. - View Dependent Claims (12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
-
-
26. A glucose monitoring system, comprising:
-
a transcutaneous electrochemical glucose sensor;
a sensor control unit adapted for placement on skin and adapted for receiving a portion of the transcutaneous electrochemical glucose sensor, the sensor control unit comprising a rf transmitter that is configured and arranged to intermittently and repeatedly transmit data related to glucose-dependent signals generated by the electrochemical glucose sensor; and
a display unit comprising a rf receiver to receive the data transmitted by the transmitter and a display to display an indication of glucose concentration, wherein the display unit is configured and arranged to determine an insulin administration protocol based on the data. - View Dependent Claims (27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)
-
-
39. A glucose monitoring system, comprising:
-
a transcutaneous electrochemical glucose sensor;
a sensor control unit adapted for placement on skin and adapted for receiving a portion of the transcutaneous electrochemical glucose sensor, the sensor control unit comprising a rf transmitter that is configured and arranged to intermittently and repeatedly transmit data related to glucose-dependent signals generated by the electrochemical glucose sensor; and
a display unit comprising a rf receiver to receive the data transmitted by the transmitter and a display to display an indication of glucose concentration, wherein the display unit is configured and arranged to analyze a plurality of glucose-dependent signals related to a particular type of episode to predict a patient'"'"'s response to future episodes of the type. - View Dependent Claims (40, 41, 42, 43, 44, 45, 46)
-
-
47. A method of monitoring glucose, the method comprising:
-
determining a glucose concentration of a patient using a glucose sensor;
collecting data including the glucose concentration in a personal display unit comprising a transmitter and a receiver;
transmitting the data to a health professional;
transmitting a message, in response to the data, from the health professional to the personal display unit; and
displaying the message from the health professional on the personal display unit. - View Dependent Claims (48, 49, 50, 51, 52, 53, 54, 55)
coupling the glucose sensor to a sensor control unit, wherein the sensor control unit is configured and arranged for disposition on skin of the patient, the sensor control unit comprising a rf transmitter, and transmitting a rf transmission signal from the sensor control unit to the personal display unit based on at least one signal generated by the glucose sensor. -
51. The method of claim 50, wherein determining a glucose concentration comprises determining a glucose concentration using the personal display unit.
-
52. The method of claim 47, further comprising activating an alarm in the personal display unit, wherein the alarm is configured for activating under one or more of the following conditions:
- hypoglycemia, impending hypoglycemia, hyperglycemia, and impending hyperglycemia.
-
53. The method of claim 47, wherein transmitting the data comprises transmitting the data to the health professional at regular intervals.
-
54. The method of claim 47, wherein transmitting the data comprises transmitting the data to the health professional when a specific condition is present, wherein the specific condition is one or more of the following:
- hypoglycemia, impending hypoglycemia, hyperglycemia, and impending hyperglycemia.
-
55. The method of claim 47, wherein transmitting the data comprises transmitting the data using a pager or an interface to a telephone system.
-
-
56. A sensor assembly to monitor an analyte, the sensor assembly comprising:
-
a transcutaneous electrochemical sensor; and
a sensor control unit adapted for placement on skin, the sensor control unit comprising a power source and a rf transmitter that is configured and arranged to intermittently and repeatedly transmit data related to analyte-dependent signals generated by the electrochemical sensor, wherein the sensor control unit is configured and arranged to both deliver power to the trancutaneous electrochemical sensor and receive the analyte-dependent signals from the transcutaneous electrochemical sensor by inductive coupling between the sensor control unit and the transcutaneous electrochemical sensor.
-
Specification